0001209191-21-012760.txt : 20210222 0001209191-21-012760.hdr.sgml : 20210222 20210222165846 ACCESSION NUMBER: 0001209191-21-012760 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210218 FILED AS OF DATE: 20210222 DATE AS OF CHANGE: 20210222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Atlas Venture Fund X, L.P. CENTRAL INDEX KEY: 0001628098 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39460 FILM NUMBER: 21661135 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-201-2700 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 10TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kymera Therapeutics, Inc. CENTRAL INDEX KEY: 0001815442 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812992166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-5314 MAIL ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-18 0 0001815442 Kymera Therapeutics, Inc. KYMR 0001628098 Atlas Venture Fund X, L.P. 300 TECHNOLOGY SQUARE, 8TH FLOOR CAMBRIDGE MA 02139 0 0 1 0 Common Stock 2021-02-18 4 J 0 1063351 0.00 D 6885631 D Represent a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund X, L.P. to its general partner and limited partners without additional consideration. This distribution was effected pursuant to a plan adopted in accordance with Rule 10b5-1 on November 17, 2020. Atlas Venture Fund X, L.P., By: Atlas Venture Associates X, L.P., its general partner, by Atlas Associates X, LLC, its general partner, By: Ommer Chohan, Chief Financial Officer /s/ Ommer Chohan 2021-02-22